SEC Form 4 · accession 0001144204-17-005935
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Katherine Anderson
Officer — Chief Financial Officer
Period of report
Feb 1, 2017
Accepted (ET)
Feb 3, 2017 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 1, 2017 | A | 10,000 | — | A | 33,875 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Received as employment compensation.
- F2Restricted shares to vest on the last day of the month of grant.